AAAAAA

   
Results: 1-8 |
Results: 8
SARUPLASE - BACKGROUND AND BIOCHEMISTRY
Authors: GUNZLER WA
Citation: Wa. Gunzler, SARUPLASE - BACKGROUND AND BIOCHEMISTRY, Reviews in contemporary pharmacotherapy, 9(6), 1998, pp. 355-362
THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL-INFARCTION WITH SARUPLASE, ASINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (SCU-PA) FROM RECOMBINANT BACTERIA
Authors: TEBBE U GUNZLER WA HOPKINS GR GRYMBOWSKI T BARTH H
Citation: U. Tebbe et al., THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL-INFARCTION WITH SARUPLASE, ASINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (SCU-PA) FROM RECOMBINANT BACTERIA, Fibrinolysis & proteolysis, 11, 1997, pp. 45-54
EFFECT OF CHANGES IN LIVER BLOOD-FLOW ON THE PHARMACOKINETICS OF SARUPLASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
Authors: VANGRIENSVEN JMT KOSTER RW HOPKINS GR BEIER H GUNZLER WA KROON R SCHOEMAKER RC COHEN AF
Citation: Jmt. Vangriensven et al., EFFECT OF CHANGES IN LIVER BLOOD-FLOW ON THE PHARMACOKINETICS OF SARUPLASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Thrombosis and haemostasis, 78(3), 1997, pp. 1015-1020
AMYLOID-BETA PEPTIDES STIMULATE TISSUE-TYPE PLASMINOGEN-ACTIVATOR BUTNOT RECOMBINANT PROUROKINASE
Authors: WNENDT S WETZELS I GUNZLER WA
Citation: S. Wnendt et al., AMYLOID-BETA PEPTIDES STIMULATE TISSUE-TYPE PLASMINOGEN-ACTIVATOR BUTNOT RECOMBINANT PROUROKINASE, Thrombosis research, 85(3), 1997, pp. 217-224
EFFECTS OF CHANGING LIVER BLOOD-FLOW BY EXERCISE AND FOOD ON KINETICSAND DYNAMICS OF SARUPLASE
Authors: VANGRIENSVEN JMT BURGGRAAF KJ GERLOFF J GUNZLER WA BEIER H KROON R HUISMAN LGM SCHOEMAKER RC KLUFT K COHEN AF
Citation: Jmt. Vangriensven et al., EFFECTS OF CHANGING LIVER BLOOD-FLOW BY EXERCISE AND FOOD ON KINETICSAND DYNAMICS OF SARUPLASE, Clinical pharmacology and therapeutics, 57(4), 1995, pp. 381-389
PHARMACOKINETICS AND PHARMACODYNAMICS OF SARUPLASE, AN UNGLYCOSYLATEDSINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
Authors: KOSTER RW COHEN AF HOPKINS GR BEIER H GUNZLER WA VANDERWOUW PA
Citation: Rw. Koster et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF SARUPLASE, AN UNGLYCOSYLATEDSINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Thrombosis and haemostasis, 72(5), 1994, pp. 740-744
PHARMACOKINETICS OF SARUPLASE, A RECOMBINANT UNGLYCOSYLATED HUMAN SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS EFFECTS ON FIBRINOLYTIC AND HEMOSTATIC PARAMETERS IN HEALTHY MALE-SUBJECTS
Authors: DEBOER A KLUFT C GERLOFF J DOOIJEWAARD G GUNZLER WA BEIER H VANDERMEER FJM COHEN AF
Citation: A. Deboer et al., PHARMACOKINETICS OF SARUPLASE, A RECOMBINANT UNGLYCOSYLATED HUMAN SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS EFFECTS ON FIBRINOLYTIC AND HEMOSTATIC PARAMETERS IN HEALTHY MALE-SUBJECTS, Thrombosis and haemostasis, 70(2), 1993, pp. 320-325
PLASMA MARKERS OF THROMBIN ACTIVITY DURING CORONARY THROMBOLYTIC THERAPY WITH SARUPLASE OR UROKINASE - NO PREDICTION OF REINFARCTION
Authors: HOFFMANN JJML MICHELS HR WINDELER J GUNZLER WA
Citation: Jjml. Hoffmann et al., PLASMA MARKERS OF THROMBIN ACTIVITY DURING CORONARY THROMBOLYTIC THERAPY WITH SARUPLASE OR UROKINASE - NO PREDICTION OF REINFARCTION, Fibrinolysis, 7(5), 1993, pp. 330-334
Risultati: 1-8 |